Jooss Karin is a director of Fate Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Gritstone bio, Inc.
5 Feb 24
4
FATE THERAPEUTICS INC
7 Jun 23
4
Gritstone bio, Inc.
6 Feb 23
4
FATE THERAPEUTICS INC
13 Jun 22
4
FATE THERAPEUTICS INC
6 Jun 22
4
Gritstone bio, Inc.
20 Apr 22
4
Gritstone bio, Inc.
19 Nov 21
4
FATE THERAPEUTICS INC
4 Jun 21
4
Gritstone Oncology, Inc.
10 Mar 21
4
FATE THERAPEUTICS INC
5 May 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Feb 24 | GRTS Gritstone Bio | Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 648,851 |
1 Feb 24 | GRTS Gritstone Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 2.46 | 235,000 | 578.10 k | 235,000 |
6 Jun 23 | FATE Fate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.52 | 40,000 | 220.80 k | 40,000 |
2 Feb 23 | GRTS Gritstone Bio | Common Stock | Grant | Acquire A | No | No | 0 | 252,763 | 0.00 | 630,147 |